PEDEVCO CORP (PED) Fundamental Analysis & Valuation

NYSEARCA:PED • US70532Y3036

Current stock price

17.97 USD
+0.95 (+5.58%)
At close:
18.07 USD
+0.1 (+0.56%)
After Hours:

This PED fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. PED Profitability Analysis

1.1 Basic Checks

  • In the past year PED was profitable.
  • PED had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: PED reported negative net income in multiple years.
  • Each year in the past 5 years PED had a positive operating cash flow.
PED Yearly Net Income VS EBIT VS OCF VS FCFPED Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • PED's Return On Assets of 7.03% is fine compared to the rest of the industry. PED outperforms 77.88% of its industry peers.
  • PED has a Return On Equity (8.29%) which is in line with its industry peers.
Industry RankSector Rank
ROA 7.03%
ROE 8.29%
ROIC N/A
ROA(3y)5.71%
ROA(5y)-5.05%
ROE(3y)6.44%
ROE(5y)-5.07%
ROIC(3y)N/A
ROIC(5y)N/A
PED Yearly ROA, ROE, ROICPED Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

  • Looking at the Profit Margin, with a value of 28.75%, PED belongs to the top of the industry, outperforming 86.54% of the companies in the same industry.
  • With a decent Gross Margin value of 63.54%, PED is doing good in the industry, outperforming 73.08% of the companies in the same industry.
  • PED's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 28.75%
GM 63.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.09%
GM growth 5Y7.61%
PED Yearly Profit, Operating, Gross MarginsPED Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. PED Health Analysis

2.1 Basic Checks

  • PED does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • PED has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for PED has been increased compared to 5 years ago.
  • PED has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PED Yearly Shares OutstandingPED Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
PED Yearly Total Debt VS Total AssetsPED Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • PED has an Altman-Z score of 46.57. This indicates that PED is financially healthy and has little risk of bankruptcy at the moment.
  • PED has a Altman-Z score of 46.57. This is amongst the best in the industry. PED outperforms 98.56% of its industry peers.
  • PED has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 46.57
ROIC/WACCN/A
WACC9.03%
PED Yearly LT Debt VS Equity VS FCFPED Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • PED has a Current Ratio of 1.10. This is a normal value and indicates that PED is financially healthy and should not expect problems in meeting its short term obligations.
  • PED's Current ratio of 1.10 is in line compared to the rest of the industry. PED outperforms 46.63% of its industry peers.
  • PED has a Quick Ratio of 1.10. This is a normal value and indicates that PED is financially healthy and should not expect problems in meeting its short term obligations.
  • PED's Quick ratio of 1.10 is in line compared to the rest of the industry. PED outperforms 57.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
PED Yearly Current Assets VS Current LiabilitesPED Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. PED Growth Analysis

3.1 Past

  • PED shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 185.71%, which is quite impressive.
  • The Revenue has decreased by -6.93% in the past year.
  • The Revenue has been growing by 24.98% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)185.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-110.74%
Revenue 1Y (TTM)-6.93%
Revenue growth 3Y35.61%
Revenue growth 5Y24.98%
Sales Q2Q%-23.08%

3.2 Future

  • PED is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -51.76% yearly.
  • Based on estimates for the next years, PED will show a very strong growth in Revenue. The Revenue will grow by 98.82% on average per year.
EPS Next Y-120.2%
EPS Next 2Y-51.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.61%
Revenue Next 2Y98.82%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PED Yearly Revenue VS EstimatesPED Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
PED Yearly EPS VS EstimatesPED Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 1 -1 2 3

More info and screens

Find the best growth stocksShow best growing peers

1

4. PED Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 89.85, which means the current valuation is very expensive for PED.
  • PED's Price/Earnings ratio is a bit more expensive when compared to the industry. PED is more expensive than 64.90% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, PED is valued quite expensively.
  • The Forward Price/Earnings Ratio is negative for PED. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 89.85
Fwd PE N/A
PED Price Earnings VS Forward Price EarningsPED Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

  • PED's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. PED is more expensive than 72.12% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as PED.
Industry RankSector Rank
P/FCF 502.19
EV/EBITDA 114.87
PED Per share dataPED EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • PED's earnings are expected to decrease with -51.76% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-51.76%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PED Dividend Analysis

5.1 Amount

  • No dividends for PED!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PED Fundamentals: All Metrics, Ratios and Statistics

PEDEVCO CORP

NYSEARCA:PED (3/20/2026, 8:16:33 PM)

After market: 18.07 +0.1 (+0.56%)

17.97

+0.95 (+5.58%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)03-20
Earnings (Next)05-13
Inst Owners2.35%
Inst Owner Change7.5%
Ins Owners9.26%
Ins Owner Change1.6%
Market Cap239.00M
Revenue(TTM)33.24M
Net Income(TTM)9.56M
Analysts80
Price TargetN/A
Short Float %N/A
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-20.03%
Min Revenue beat(2)-28.89%
Max Revenue beat(2)-11.17%
Revenue beat(4)1
Avg Revenue beat(4)-8.08%
Min Revenue beat(4)-28.89%
Max Revenue beat(4)12.69%
Revenue beat(8)5
Avg Revenue beat(8)1.88%
Revenue beat(12)6
Avg Revenue beat(12)1.27%
Revenue beat(16)9
Avg Revenue beat(16)1.85%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 89.85
Fwd PE N/A
P/S 51.63
P/FCF 502.19
P/OCF 100.24
P/B 14.88
P/tB 14.88
EV/EBITDA 114.87
EPS(TTM)0.2
EY1.11%
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.04
FCFY0.2%
OCF(TTM)0.18
OCFY1%
SpS0.35
BVpS1.21
TBVpS1.21
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.33
Profitability
Industry RankSector Rank
ROA 7.03%
ROE 8.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 28.75%
GM 63.54%
FCFM 10.28%
ROA(3y)5.71%
ROA(5y)-5.05%
ROE(3y)6.44%
ROE(5y)-5.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.91%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.09%
GM growth 5Y7.61%
F-Score5
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 84.25%
Cap/Sales 41.23%
Interest Coverage N/A
Cash Conversion 121.81%
Profit Quality 35.76%
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 46.57
F-Score5
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)202.57%
Cap/Depr(5y)160.14%
Cap/Sales(3y)75.11%
Cap/Sales(5y)87.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)185.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-110.74%
EPS Next Y-120.2%
EPS Next 2Y-51.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.93%
Revenue growth 3Y35.61%
Revenue growth 5Y24.98%
Sales Q2Q%-23.08%
Revenue Next Year-2.61%
Revenue Next 2Y98.82%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-140.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year186.91%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y123.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.75%
OCF growth 3Y28.83%
OCF growth 5Y50.2%

PEDEVCO CORP / PED Fundamental Analysis FAQ

What is the fundamental rating for PED stock?

ChartMill assigns a fundamental rating of 5 / 10 to PED.


What is the valuation status for PED stock?

ChartMill assigns a valuation rating of 1 / 10 to PEDEVCO CORP (PED). This can be considered as Overvalued.


What is the profitability of PED stock?

PEDEVCO CORP (PED) has a profitability rating of 4 / 10.


Can you provide the financial health for PED stock?

The financial health rating of PEDEVCO CORP (PED) is 7 / 10.


What is the earnings growth outlook for PEDEVCO CORP?

The Earnings per Share (EPS) of PEDEVCO CORP (PED) is expected to decline by -120.2% in the next year.